Cargando…

A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types

Genetic alterations in PI3K (phosphoinositide 3-kinase) signalling are common in cancer and include deletions in PTEN (phosphatase and tensin homologue deleted on chromosome 10), amplifications of PIK3CA and mutations in two distinct regions of the PIK3CA gene. This suggests drugs targeting PI3K, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jamieson, Stephen, Flanagan, Jack U., Kolekar, Sharada, Buchanan, Christina, Kendall, Jackie D., Lee, Woo-Jeong, Rewcastle, Gordon W., Denny, William A., Singh, Ripudaman, Dickson, James, Baguley, Bruce C., Shepherd, Peter R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174055/ https://www.ncbi.nlm.nih.gov/pubmed/21668414 http://dx.doi.org/10.1042/BJ20110502

Ejemplares similares

Inhibitors of pan-PI3K Signaling Synergize with BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth
por: Sweetlove, Melanie, et al.
Publicado: (2015)

Biological characterization of SN32976, a selective inhibitor of PI3K and mTOR with preferential activity to PI3Kα, in comparison to established pan PI3K inhibitors
por: Rewcastle, Gordon W, et al.
Publicado: (2017)

Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK
por: Tran, Khanh B., et al.
Publicado: (2021)

Oncogenic Mutations of p110α Isoform of PI 3-Kinase Upregulate Its Protein Kinase Activity
por: Buchanan, Christina M., et al.
Publicado: (2013)

Enzyme activity effects of N-terminal His-tag attached to catalytic sub-unit of phosphoinositide-3-kinase
por: Dickson, James M. J., et al.
Publicado: (2013)

Phosphoinositide Recognition Sites Are Blocked by Metabolite Attachment
por: Kervin, Troy A., et al.
Publicado: (2021)

Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation
por: Yamaguchi, Hideki, et al.
Publicado: (2011)

Essential Role of the p110β Subunit of Phosphoinositide 3-OH Kinase in Male Fertility
por: Ciraolo, Elisa, et al.
Publicado: (2010)

Response to BRAF-targeted Therapy Is Enhanced by Cotargeting VEGFRs or WNT/β-Catenin Signaling in BRAF-mutant Colorectal Cancer Models
por: Tran, Khanh B., et al.
Publicado: (2022)

Phosphoinositide-3-kinases p110α and p110β mediate S phase entry in astroglial cells in the marginal zone of rat neocortex
por: Müller, Rabea, et al.
Publicado: (2013)

Effects of acutely inhibiting PI3K isoforms and mTOR on regulation of glucose metabolism in vivo
por: Smith, Greg C., et al.
Publicado: (2012)

Cell Electrosensitization Exists Only in Certain Electroporation Buffers
por: Dermol, Janja, et al.
Publicado: (2016)

Deficiency of p110δ Isoform of the Phosphoinositide 3 Kinase Leads to Enhanced Resistance to Leishmania donovani
por: Khadem, Forough, et al.
Publicado: (2014)

Dynamics of the Phosphoinositide 3-Kinase p110δ Interaction with p85α and Membranes Reveals Aspects of Regulation Distinct from p110α
por: Burke, John E., et al.
Publicado: (2011)

Class I Phosphoinositide 3-Kinase PIK3CA/p110α and PIK3CB/p110β Isoforms in Endometrial Cancer
por: Mazloumi Gavgani, Fatemeh, et al.
Publicado: (2018)

Recent advances in understanding phosphoinositide signaling in the nervous system
por: Dickson, Eamonn James
Publicado: (2019)

Genetic or Pharmaceutical Blockade of Phosphoinositide 3-Kinase P110δ Prevents Chronic Rejection of Heart Allografts
por: Ying, Huijun, et al.
Publicado: (2012)

PAQR3 Modulates Insulin Signaling by Shunting Phosphoinositide 3-Kinase p110α to the Golgi Apparatus
por: Wang, Xiao, et al.
Publicado: (2013)

Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110α
por: Ismail, Mohamed, et al.
Publicado: (2023)

Roles of Gβγ in membrane recruitment and activation of p110γ/p101 phosphoinositide 3-kinase γ
por: Brock, Carsten, et al.
Publicado: (2003)

Activation of Myocardial Phosphoinositide-3-Kinase p110α Ameliorates Cardiac Dysfunction and Improves Survival in Polymicrobial Sepsis
por: Li, Chuanfu, et al.
Publicado: (2012)

The Proclivity of Women to Cancerous Diseases, and to Certain Benign Tumours
Publicado: (1892)

Dysregulation of Phosphoinositide 5-Phosphatases and Phosphoinositides in Alzheimer's Disease
por: Ando, Kunie, et al.
Publicado: (2021)

Certain Polymorphisms in SP110 Gene Confer Susceptibility to Tuberculosis: A Comprehensive Review and Updated Meta-Analysis
por: Zhang, Shuai, et al.
Publicado: (2017)

Phosphoinositide 3-Kinase (PI3K) Subunit p110δ Is Essential for Trophoblast Cell Differentiation and Placental Development in Mouse
por: Hu, Xiwen, et al.
Publicado: (2016)

Phosphoinositide 3-Kinase p110 Delta Differentially Restrains and Directs Naïve Versus Effector CD8(+) T Cell Transcriptional Programs
por: Spinelli, Laura, et al.
Publicado: (2021)

Phosphoinositides and phagocytosis
por: Gillooly, David J., et al.
Publicado: (2001)

Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines
por: Leung, Euphemia Y., et al.
Publicado: (2015)

On Certain Supposed Injuries by Vaccination in North Germany in 1885
por: Buchanan, George
Publicado: (1887)

Initiation of human astrovirus type 1 infection was blocked by inhibitors of phosphoinositide 3-kinase
por: Tange, Shoichiro, et al.
Publicado: (2013)

Phosphoinositide 3-Kinase P110δ-Signaling Is Critical for Microbiota-Activated IL-10 Production by B Cells that Regulate Intestinal Inflammation
por: Oka, Akihiko, et al.
Publicado: (2019)

Structure of the phosphoinositide 3-kinase (PI3K) p110γ-p101 complex reveals molecular mechanism of GPCR activation
por: Rathinaswamy, Manoj K., et al.
Publicado: (2021)

Identification of cyclohexanone derivatives that act as catalytic inhibitors of topoisomerase I: effects on tamoxifen-resistant MCF-7 cancer cells
por: Leung, Euphemia, et al.
Publicado: (2011)

Phosphoinositides and Receptor Mechanisms
por: Jen, Joanna
Publicado: (1987)

Phosphoinositides as membrane organizers
por: Posor, York, et al.
Publicado: (2022)

Impact of rs361072 in the Phosphoinositide 3-Kinase p110β Gene on Whole-Body Glucose Metabolism and Subunit Protein Expression in Skeletal Muscle
por: Ribel-Madsen, Rasmus, et al.
Publicado: (2010)

Author Correction: Phosphoinositide 3-Kinase (PI3K) Subunit p110δ Is Essential for Trophoblast Cell Differentiation and Placental Development in Mouse
por: Hu, Xiwen, et al.
Publicado: (2020)

Biophysical physiology of phosphoinositide rapid dynamics and regulation in living cells
por: Jensen, Jill B., et al.
Publicado: (2022)

Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: A valuable model for studying the impact of genetic diversity in melanoma
por: Tran, Khanh B., et al.
Publicado: (2020)

Relationships between Signaling Pathway Usage and Sensitivity to a Pathway Inhibitor: Examination of Trametinib Responses in Cultured Breast Cancer Lines
por: Leung, Euphemia Y., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_uc9sdp92sgvg1f53c9h9pu95m3